Macquarie Group’s bluebird bio BLUE Stock Holding History

Macquarie Group’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-63	Closed	-$6	–	2577
2022 Q1	$6	Hold	63	–	–	﹤0.01%	2568
2021 Q4	$13K	Sell	63 -123	-66%	-$29K	﹤0.01%	2475
2021 Q3	$46K	Hold	186	–	–	﹤0.01%	2253
2021 Q2	$77K	Hold	186	–	–	﹤0.01%	2041
2021 Q1	$73K	Sell	186 -52	-22%	-$25.6K	﹤0.01%	1984
2020 Q4	$134K	Sell	238 -740	-76%	-$469K	﹤0.01%	1804
2020 Q3	$684K	Sell	978 -28	-3%	-$21.8K	﹤0.01%	1332
2020 Q2	$795K	Sell	1,006 -290	-22%	-$219K	﹤0.01%	1255
2020 Q1	$772K	Buy	1,296 +65	+5%	+$63.3K	﹤0.01%	1158
2019 Q4	$1.4M	Buy	1,231 +165	+15%	+$179K	﹤0.01%	1144
2019 Q3	$1.27M	Buy	+1,066	New	+$1.63M	﹤0.01%	1148
2019 Q2	–	Sell	-35	Closed	-$72K	–	1834
2019 Q1	$72K	Buy	+35	New	+$61.6K	﹤0.01%	1553
2018 Q1	–	Sell	-1,475	Closed	-$3.4M	–	2192
2017 Q4	$3.4M	Buy	1,475 +34	+2%	+$69K	0.01%	879
2017 Q3	$2.56M	Buy	1,441 +563	+64%	+$787K	﹤0.01%	916
2017 Q2	$1.2M	Hold	878	–	–	﹤0.01%	1112
2017 Q1	$1.03M	Sell	878 -2	-0.2%	-$2.04K	﹤0.01%	1170
2016 Q4	$703K	Buy	+880	New	+$699K	﹤0.01%	1253
2016 Q2	–	Sell	-831	Closed	-$457K	–	1572
2016 Q1	$457K	Buy	+831	New	+$510K	﹤0.01%	1245

Other funds holding BLUE

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group's BLUE Position: Q2 2022 in Review

Macquarie Group sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 63 shares — an estimated $6 sold.

Macquarie Group first reported a position in BLUE in Q1 2016 and held it in 18 quarters. The position peaked at $3.4M in Q4 2017. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

Macquarie Group reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
Macquarie Group sold 63 bluebird bio shares in Q2 2022, an estimated $6.
Macquarie Group first reported a position in bluebird bio in Q1 2016 and held it in 18 quarters.
Macquarie Group's bluebird bio position peaked at $3.4M in Q4 2017.
151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.